<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.52575/2687-0940-2024-47-3-293-306</article-id><article-id pub-id-type="publisher-id">203</article-id><article-categories><subj-group subj-group-type="heading"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Reverse Left Ventricular Remodeling in Patients with Multivessel Myocardial Infarction after Revascularization&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Reverse Left Ventricular Remodeling in Patients with Multivessel Myocardial Infarction after Revascularization&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zinsou</surname><given-names>Janvier</given-names></name><name xml:lang="en"><surname>Zinsou</surname><given-names>Janvier</given-names></name></name-alternatives><email>zjanv1993@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Mansur</surname><given-names>Ahmed T.A.</given-names></name><name xml:lang="en"><surname>Mansur</surname><given-names>Ahmed T.A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Perutsky</surname><given-names>Dmitry N.</given-names></name><name xml:lang="en"><surname>Perutsky</surname><given-names>Dmitry N.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Pribylov</surname><given-names>Sergey A.</given-names></name><name xml:lang="en"><surname>Pribylov</surname><given-names>Sergey A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Belousova</surname><given-names>Oksana N.</given-names></name><name xml:lang="en"><surname>Belousova</surname><given-names>Oksana N.</given-names></name></name-alternatives><email>belousova_on@bsuedu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2024</year></pub-date><volume>47</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2024/3/АПМ_2024_293-306_Sh7HBC4.pdf" /><abstract xml:lang="ru"><p>The role of factors leading to reverse LV remodeling in patients with multivessel ischemic heart disease after percutaneous coronary intervention (PCI) has not been sufficiently studied. The purpose of this article is to provide a brief and concise review of the current understanding of the pathophysiology, clinical predictors, and studies of LV reverse remodeling after complete and incomplete revascularization in patients with multivessel coronary disease. Materials and methods. A systematic review and meta-analysis was conducted in the search systems: eLIBRARY.RU, PubMed, Medline, ResearchGate, Connected papers and Google Scholar mainly from 2019 to 2024 (85.7&amp;nbsp;%). Results. The cumulative evidence suggests that key factors that can initiate and maintain remodeling processes include myocardial ischemic injury, chronic inflammation, neurohormonal activation, and oxidative stress. A decrease in all these factors can lead to reverse myocardial remodeling. This is possible with complete revascularization during primary PCI, which leads to improved clinical course and reduced 30-day, 1-year and 3-year mortality rates. A combination of biomarkers from different groups may be suitable for predicting reverse remodeling (brain natriuretic peptide precursor-N-terminal natriuretic hormone propeptide, high-sensitivity troponins, C-reactive protein and creatinine kinase), as well as echocardiographic findings, especially 3D-echocardiographic assessments of ventricular volumes, mass and ejection fraction. Conclusion. Complete revascularization is feasible and has great advantages over revascularization of only one infarct-related coronary artery.</p></abstract><trans-abstract xml:lang="en"><p>The role of factors leading to reverse LV remodeling in patients with multivessel ischemic heart disease after percutaneous coronary intervention (PCI) has not been sufficiently studied. The purpose of this article is to provide a brief and concise review of the current understanding of the pathophysiology, clinical predictors, and studies of LV reverse remodeling after complete and incomplete revascularization in patients with multivessel coronary disease. Materials and methods. A systematic review and meta-analysis was conducted in the search systems: eLIBRARY.RU, PubMed, Medline, ResearchGate, Connected papers and Google Scholar mainly from 2019 to 2024 (85.7&amp;nbsp;%). Results. The cumulative evidence suggests that key factors that can initiate and maintain remodeling processes include myocardial ischemic injury, chronic inflammation, neurohormonal activation, and oxidative stress. A decrease in all these factors can lead to reverse myocardial remodeling. This is possible with complete revascularization during primary PCI, which leads to improved clinical course and reduced 30-day, 1-year and 3-year mortality rates. A combination of biomarkers from different groups may be suitable for predicting reverse remodeling (brain natriuretic peptide precursor-N-terminal natriuretic hormone propeptide, high-sensitivity troponins, C-reactive protein and creatinine kinase), as well as echocardiographic findings, especially 3D-echocardiographic assessments of ventricular volumes, mass and ejection fraction. Conclusion. Complete revascularization is feasible and has great advantages over revascularization of only one infarct-related coronary artery.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>myocardial remodeling</kwd><kwd>ST-segment elevation myocardial infarction</kwd><kwd>multivessel disease</kwd><kwd>revascularization</kwd><kwd>percutaneous coronary intervention</kwd><kwd>echocardiography</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial remodeling</kwd><kwd>ST-segment elevation myocardial infarction</kwd><kwd>multivessel disease</kwd><kwd>revascularization</kwd><kwd>percutaneous coronary intervention</kwd><kwd>echocardiography</kwd></kwd-group></article-meta></front><back><ack><p>The work was carried out without external sources of funding.</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Kamyshnikova L.A., Efremova O.A. 2017. Vlijanie soputstvujushhih zabolevanij na remodelirovanie i disfunkciju serdca pri hronicheskoj serdechnoj nedostatochnosti s sohrannoj frakciej vybrosa [Impact of Comorbidities on Cardiac Remodeling and Dysfunction in Chronic Heart Failure with Preserved Ejection Fraction]. Klinicheskaja medicina [Clinical Medicine]. 95(12): 1070&amp;ndash;1076. doi: 10.18821/0023-2149-2017-95-12-1070-1076</mixed-citation></ref><ref id="B2"><mixed-citation>Kamyshnikova L.A., Efremova O.A. 2012. Strukturno-funkcional&amp;#39;nye izmenenija miokarda u bol&amp;#39;nyh hronicheskoj serdechnoj nedostatochnost&amp;#39;ju pri lechenii spironolaktonom [Structural and Functional Changes in the Myocardium in Patients with Chronic Heart Failure During Treatment with Spironolactone]. Klinicheskaja medicina [Clinical Medicine]. 90(5): 25&amp;ndash;28.</mixed-citation></ref><ref id="B3"><mixed-citation>Osipova O.A., Bukatov V.V. 2020. Osobennosti techeniya infarkta miokarda s pod``emom segmenta ST u bol`ny`x pozhilogo i starcheskogo vozrasta [Features of the Course of Myocardial Infarction with ST Segment Elevation in Elderly and Senile Patients]. Nauchny`e rezul`taty` biomedicinskix issledovanij [Scientific Results of Biomedical Research]. 6(3): 402&amp;ndash;416. doi: 10.18413/2658-6533-2020-6-3-0-10</mixed-citation></ref><ref id="B4"><mixed-citation>Barberato S.H., Souza A.M., Costantini C.O., Costantini C.R.F. 2013. Rela&amp;ccedil;&amp;atilde;o E/ e`na predi&amp;ccedil;&amp;atilde;o da remodela&amp;ccedil;&amp;atilde;o do ventr&amp;iacute;culo esquerdo ap&amp;oacute;s infarto agudo do mioc&amp;aacute;rdio (E/ e` ratio prediction of left ventricular remodeling after acute myocardial infarction). Rev bras ecocardiogr imagem cardiovasc. 26(3): 189&amp;ndash;195.</mixed-citation></ref><ref id="B5"><mixed-citation>Berezin A.E., Berezin A.A. 2020. Adverse Cardiac Remodeling after Acute Myocardial Infarction: Old and New Biomarkers. Dis Markers. 2020: 1215802. doi: 10.1155/2020/1215802.</mixed-citation></ref><ref id="B6"><mixed-citation>Boukenna M., Rougier J.S., Aghagolzadeh P., Pradervand S., Guichard S., H&amp;auml;mmerli A.F., Pedrazzini T., Abriel H. 2023. Multiomics Uncover the Proinflammatory Role of Trpm4 Deletion after Myocardial Infarction in Mice. Am. J. Physiol. Heart. Circ. Physiol.&amp;nbsp;1; 324(4): H504-H518.&amp;nbsp;doi: 10.1152/ajpheart.00671.2022.</mixed-citation></ref><ref id="B7"><mixed-citation>Bryer E., Stein E., Goldberg S. 2020. Multivessel Coronary Artery Disease: The Limitations of a &amp;quot;One-Size-Fits-All&amp;quot; Approach. Mayo. Clin. Proc. Innov. Qual. Outcomes. 4(6): 638&amp;ndash;641. doi: 10.1016/j.mayocpiqo.2020.07.014.</mixed-citation></ref><ref id="B8"><mixed-citation>Bugger H., Pfeil K. 2020. Mitochondrial ROS in Myocardial Ischemia Reperfusion and Remodeling. Biochim. Biophys. Acta. Mol. Basis. Dis. 1866(7): 165768. doi: 10.1016/j.bbadis.2020.165768.</mixed-citation></ref><ref id="B9"><mixed-citation>Chud&amp;yacute; M., Goncalvesov&amp;aacute; E. 2022. Prediction of Left Ventricular Reverse Remodelling: A Mini Review on Clinical Aspects. Cardiology. 147(5&amp;ndash;6): 521&amp;ndash;528. doi: 10.1159/000526986.</mixed-citation></ref><ref id="B10"><mixed-citation>Daubert M.A., Massaro J., Liao L., Pershad A., Mulukutla S., Magnus Ohman E., Popma J., O&amp;#39;Neill W.W., Douglas P.S. 2015. High-Risk Percutaneous Coronary Intervention is Associated with Reverse Left Ventricular Remodeling and Improved Outcomes in Patients with Coronary Artery Disease and Reduced Ejection Fraction. Am. Heart. J. 170: 550&amp;ndash;558. doi: 10.1016/j.ahj.2015.06.013.</mixed-citation></ref><ref id="B11"><mixed-citation>Diletti R., den Dekker W.K., Bennett J., Schotborgh C.E., van der Schaaf R., Sabat&amp;eacute; M., Moreno R., Ameloot K., van Bommel R., Forlani D., van Reet B., Esposito G., Dirksen M.T., Ruifrok W.P.T., Everaert B.R.C., Van Mieghem C., Elscot J.J., Cummins P., Lenzen M., Brugaletta S., Boersma E., Van Mieghem N.M.; BIOVASC Investigators. 2023.&amp;nbsp; Immediate Versus Staged Complete Revascularisation in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease (BIOVASC): a Prospective, Open-Label, Non-Inferiority, Randomised Trial. Lancet. 401(10383): 1172&amp;ndash;1182. doi: 10.1016/S0140-6736(23)00351-3.</mixed-citation></ref><ref id="B12"><mixed-citation>Heusch G. 2020. Myocardial Ischaemia-Reperfusion Injury and Cardioprotection in Perspective. Nat. Rev. Cardiol. 17(12): 773&amp;ndash;789. doi: 10.1038/s41569-020-0403-y.</mixed-citation></ref><ref id="B13"><mixed-citation>Hoque M.M., Gbadegoye J.O., Hassan F.O., Raafat A., Lebeche D. 2024. Cardiac Fibrogenesis: an Immuno-Metabolic Perspective. Front Physiol. Mar 21; 15: 1336551. doi: 10.3389/fphys.2024.1336551.</mixed-citation></ref><ref id="B14"><mixed-citation>Huang-Chung Chen, Tzu-Hsien Tsai, Fang H.Y., Sun C.K., Lin Y.C., Leu S., Chung S.Y., Chai H.T., Yang&amp;nbsp;C.H., Hsien Y.K., Wu C.J., Yip H.K. 2010. Benefit of Revascularization in Non-Infarct-Related Artery in Multivessel Disease Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Int. Heart. J. 51(5): 319&amp;ndash;24. doi: 10.1536/ihj.51.319.</mixed-citation></ref><ref id="B15"><mixed-citation>Jiang H., Fang T., Cheng Z. 2023. Mechanism of Heart Failure after Myocardial Infarction. J. Int. Med. Res. Oct; 51(10): 3000605231202573. doi: 10.1177/03000605231202573.</mixed-citation></ref><ref id="B16"><mixed-citation>Kyhl K., Ahtarovski K.A., Nepper-Christensen L., Ekstr&amp;ouml;m K., Ghotbi A.A., Schoos M., G&amp;ouml;ransson C., Bertelsen L., Helqvist S., Holmvang L., J&amp;oslash;rgensen E., Pedersen F., Saunam&amp;auml;ki K., Clemmensen P., De Backer O., H&amp;oslash;fsten D.E., K&amp;oslash;ber L., Kelb&amp;aelig;k H., Vejlstrup N., L&amp;oslash;nborg J., Engstr&amp;oslash;m T.&amp;nbsp;2019. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. JACC Cardiovasc Interv. 12(8): 721&amp;ndash;730. doi: 10.1016/j.jcin.2019.01.248.</mixed-citation></ref><ref id="B17"><mixed-citation>Liu Y., Cui C., Li Y., Wang Y., Hu Y., Bai M., Huang D., Zheng Q., Liu L. 2022. Predictive Value of the Echocardiographic Noninvasive Myocardial Work Index for Left Ventricular Reverse Remodeling in Patients with Multivessel Coronary Artery Disease after Percutaneous Coronary Intervention. Quant Imaging Med. Surg. Jul; 12(7): 3725&amp;ndash;3737. doi: 10.21037/qims-21-1066.</mixed-citation></ref><ref id="B18"><mixed-citation>Liu Z., Liu L., Cheng J., Zhang H. 2021.&amp;nbsp; Risk Prediction Model Based on Biomarkers of Remodeling in Patients with Acute Anterior ST-Segment Elevation Myocardial Infarction. Med. Sci. Monit. 227: e927404. doi: 10.12659/MSM.927404.</mixed-citation></ref><ref id="B19"><mixed-citation>Lotti R., D.E. Marzo V., Della Bona R., Porto I., Rosa G.M. 2023. Speckle-Tracking Echocardiography: State of Art and its Applications. Minerva Med. 114(4): 500&amp;ndash;515. doi: 10.23736/S0026-4806.21.07317-1.</mixed-citation></ref><ref id="B20"><mixed-citation>Martins D., Garcia L.R., Queiroz D.A.R., Lazzarin T., Tonon C.R., Balin P.D.S., Polegato B.F., de&amp;nbsp;Paiva&amp;nbsp;S.A.R., Azevedo P.S., Minicucci M.F., Zornoff L. Oxidative Stress as a Therapeutic Target of Cardiac Remodeling. Antioxidants (Basel). 2022 Nov 30; 11(12): 2371. doi: 10.3390/antiox11122371.</mixed-citation></ref><ref id="B21"><mixed-citation>Mehta S.R., Wood D.A., Storey R.F., Mehran R., Bainey K.R., Nguyen H., Meeks B., Di Pasquale G., L&amp;oacute;pez-Send&amp;oacute;n J., Faxon D.P., Mauri L., Rao S.V., Feldman L., Steg P.G., Avezum &amp;Aacute;., Sheth T., Pinilla-Echeverri N., Moreno R., Campo G., Wrigley B., Kedev S., Sutton A., Oliver R., Rod&amp;eacute;s-Cabau J., Stanković G., Welsh R., Lavi S., Cantor W.J., Wang J., Nakamya J., Bangdiwala S.I., Cairns&amp;nbsp;J.A.; 2019. Complete Trial Steering Committee and Investigators. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N. Engl. J. Med. Oct 10; 381(15): 1411&amp;ndash;1421. doi: 10.1056/NEJMoa1907775.</mixed-citation></ref><ref id="B22"><mixed-citation>Ndrepepa G., Kastrati A. 2023. Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy. J. Clin. MedAug 27; 12(17): 5592. doi: 10.3390/jcm12175592.</mixed-citation></ref><ref id="B23"><mixed-citation>Nogueira-Garcia B., Vilela M., Oliveira C., Caldeira D., Martins A.M., Nobre Menezes M. 2024. A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions. J. Pers. Med. May 10; 14(5): 506. doi: 10.3390/jpm14050506.</mixed-citation></ref><ref id="B24"><mixed-citation>Obokata M., Reddy Y.N.V., Borlaug B.A. 2020. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. Jan; 13(1 Pt 2): 245&amp;ndash;257. doi: 10.1016/j.jcmg.2018.12.034.</mixed-citation></ref><ref id="B25"><mixed-citation>Popa D.M., Macovei L., Moscalu M., Sascău R.A., Stătescu C. 2023. The Prognostic Value of Creatine Kinase-MB Dynamics after Primary Angioplasty in ST-Elevation Myocardial Infarctions. Diagnostics. 13(19): 3143. doi.org/10.3390/diagnostics13193143.</mixed-citation></ref><ref id="B26"><mixed-citation>Ralapanawa U., Sivakanesan R. 2021. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J. Epidemiol. Glob. Health. Jun; 11(2): 169&amp;ndash;177. doi: 10.2991/jegh.k.201217.001.</mixed-citation></ref><ref id="B27"><mixed-citation>Rumiz E., Valero E., Fernandez C., Vilar J.V., Pellicer M., Cubillos A., Berenguer A., Facila L., Va&amp;ntilde;o J., Nu&amp;ntilde;ez J. 2024. In-Hospital Versus After-Discharge Complete Revascularization in Patients with ST Segment Elevation Myocardial Infarction and Multivessel Disease. REVIVA-ST trial. PLoS One. May 14; 19(5): e0303284. doi: 10.1371/journal.pone.0303284.</mixed-citation></ref><ref id="B28"><mixed-citation>Frantz S., Hundertmark M.J., Schulz-Menger J., Bengel F.M., Bauersachs J. 2022. Left Ventricular Remodelling Post-Myocardial Infarction: Pathophysiology, Imaging, and Novel Therapies. Eur. Heart. J. 43(27): 2549&amp;ndash;2561. doi: 10.1093/eurheartj/ehac223.</mixed-citation></ref><ref id="B29"><mixed-citation>Tsao C.W., Aday A.W., Almarzooq Z.I., Anderson C.A.M., Arora P., Avery C.L., Baker-Smith C.M., Beaton&amp;nbsp;A.Z., Boehme A.K., Buxton A.E., Commodore-Mensah Y., Elkind M.S.V., Evenson K.R., Eze-Nliam C., Fugar S., Generoso G., Heard D.G., Hiremath S., Ho J.E., Kalani R., Kazi D.S., Ko&amp;nbsp;D., Levine D.A., Liu J., Ma J., Magnani J.W., Michos E.D., Mussolino M.E., Navaneethan S.D., Parikh&amp;nbsp;N.I., Poudel R., Rezk-Hanna M., Roth G.A., Shah N.S., St-Onge M.P., Thacker E.L., Virani&amp;nbsp;S.S., Voeks J.H., Wang N.Y., Wong N.D., Wong S.S., Yaffe K., Martin S.S.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2023. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 147(8): e93-e621. doi: 10.1161/CIR.0000000000001123.</mixed-citation></ref><ref id="B30"><mixed-citation>Węgiel M., Rakowski T. 2021. Circulating Biomarkers as Predictors of Left Ventricular Remodeling after Myocardial Infarction. Postepy Kardiol Interwencyjnej. 17(1): 21&amp;ndash;32. doi: 10.5114/aic.2021.104764.</mixed-citation></ref><ref id="B31"><mixed-citation>Wood D.A., Cairns J.A., Wang J., Mehran R., Storey R.F., Nguyen H., Meeks B., Kunadian V., Tanguay&amp;nbsp;J.F., Kim H.H., Cheema A., Dehghani P., Natarajan M.K., Jolly S.S., Amerena J., Keltai M., James S., Hlinomaz O., Niemela K., Al Habib K., Lewis B.S., Nguyen M., Sarma J., Dzavik V., Della Siega&amp;nbsp;A., Mehta S.R.; COMPLETE Investigators. 2021. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. J. Am. Coll. Cardiol.&amp;nbsp;74(22): 2713&amp;ndash;2723.&amp;nbsp;doi: 10.1016/j.jacc.2019.09.051.</mixed-citation></ref><ref id="B32"><mixed-citation>Wu V.C., Kitano T., Chu P.H., Takeuchi M. 2023. Left Ventricular Volume and Ejection Fraction Measurements by Fully Automated 3D Echocardiography Left Chamber Quantification Software Versus CMR: A Systematic Review and Meta-Analysis. J. Cardiol. Jan; 81(1): 19&amp;ndash;25. doi: 10.1016/j.jjcc.2022.08.007.</mixed-citation></ref><ref id="B33"><mixed-citation>Yin X., Yin X., Pan X., Zhang J., Fan X., Li J., Zhai X., Jiang L., Hao P., Wang J., Chen Y. 2023. Post-Myocardial Infarction Fibrosis: Pathophysiology, Examination, and Intervention. Front Pharmacol. Mar 28; 14: 1070973. doi: 10.3389/fphar.2023.1070973.</mixed-citation></ref><ref id="B34"><mixed-citation>Yousif Ahmad, Petrie M.C., Jolicoeur E.M., Madhavan M.V., Velazquez E.J., Moses J.W., Lansky A.J., Stone G.W. 2022.&amp;nbsp;PCI in Patients with Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes. Journal of the Society for Cardiovascular Angiography &amp;amp; Interventions, Volume 1, Issue 2, 2022, 100020, ISSN 2772-9303, doi.org/10.1016/j.jscai.2022.100020.</mixed-citation></ref><ref id="B35"><mixed-citation>Zhang S., Zhou Q., Li X., Wang Y., Ma L., Huang D., Li G. 2024. Value of 2D Speckle Tracking Technique Combined with Real-Time 3-Dimensional Echocardiography in the Evaluation of the Right Atrial Function in Patients with 3-Branch Coronary Artery Disease without Myocardial Infarction. Medicine (Baltimore). May 3; 103(18): e38058. doi: 10.1097/MD.0000000000038058.</mixed-citation></ref></ref-list></back></article>